5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

NCT05452772 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Tobacco Use Disorder

Interventions

DRUG: Psilocybin
DRUG: Niacin

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]
[object Object]